ICD-9-CM C&M March 2011 Diagnosis Agenda

ICD-9-CM C&M March 2011 Diagnosis Agenda

ICD-10 Coordination and Maintenance Committee Meeting September 22-23, 2015 Diagnosis Agenda Welcome and announcements Donna Pickett, MPH, RHIA Co-Chair, ICD-10 Coordination and Maintenance Committee Diagnosis Topics: Contents Abscess of Anal and Rectal Regions ............................................................................... 12 Cheryl Bullock Garth H. Utter, MD MSc Patient Assessment and Outcome Committee Outcome of the American Association for the Surgery of Trauma Acquired Hydrocephalus ................................................................................................. 15 Donna Pickett Amblyopia Suspect .......................................................................................................... 16 Shannon McConnell Lamptey Michael X Repka, M.D., MBA Medical Director of Government Affairs American Academy of Ophthalmology Professor of Ophthalmology and Pediatrics Johns Hopkins University School of Medicine Amyotrophic Lateral Sclerosis (ALS) ............................................................................ 17\ Donna Pickett Asthma Control Status: Controlled and Uncontrolled ..................................................... 18 Cheryl Bullock Elizabeth Matsu, MD, MHS American Academy of Allergy Asthma and Immunology (AAAAI) Professor of Pediatrics, Epidemiology, and Environmental Health Sciences at Johns Hopkins University Atrial Fibrillation ............................................................................................................. 20 David Berglund, MD Chronic hepatitis vs. hepatitis carrier............................................................................... 23 David Berglund, MD ICD-10 Coordination and Maintenance Committee Meeting September 22-23, 2015 Clostridium difficile ......................................................................................................... 25 Cheryl Bullock Garth H. Utter, MD MSc Patient Assessment and Outcome Committee Outcome of the American Association for the Surgery of Trauma Contact with knife, sword or dagger ................................................................................ 26 Shannon McConnell Lamptey Encounter and Surveillance Codes for Implantable Subdermal Contraceptives ............. 27 Donna Pickett Charles DuBose Jr., MD Merk Pharmaceuticals Encounter for examination of eyes and vision with abnormal findings .......................... 28 Shannon McConnell Lamptey Michael X Repka, M.D., MBA Medical Director of Government Affairs American Academy of Ophthalmology Professor of Ophthalmology and Pediatrics Johns Hopkins University School of Medicine End Stage Heart Failure, Right Heart Failure, and Biventricular Heart Failure .............. 29 David Berglund, MD External Cause Codes for Work-related Musculoskeletal Disorders Caused by Ergonomic Hazards ............................................................................................................................ 34 Shannon McConnell Lamptey Alysha R. Meyers, PhD, CPE Epidemiologist, Centers for Disease Control and Prevention National Institute for Occupational Safety and Health Gingival recession ............................................................................................................ 37 Shannon McConnell Lamptey Heart Failure with Reduced Ejection Fraction, and with Normal Ejection Fraction ……38 David Berglund, MD Hepatic Encephalopathy .................................................................................................. 39 Shannon McConnell Lamptey Joe Harper, PharmD Senior Director, Medical Affairs Valeant Pharmaceuticals North America LLC High Output Heart Failure ............................................................................................... 41 David Berglund, MD Hypertension in Pregnancy .............................................................................................. 42 Traci Ramirez Hypophosphatasia ............................................................................................................ 44 Uchenna Iloeje, MD Alexion Pharmaceuticals Infection Following a Procedure ...................................................................................... 46 Cheryl Bullock Garth H. Utter, MD MSc Patient Assessment and Outcome Committee Outcome of the American Association for the Surgery of Trauma 2 ICD-10 Coordination and Maintenance Committee Meeting September 22-23, 2015 Inflammatory Disorders of Breast ................................................................................... 48 Shannon McConnell Lamptey Garth H. Utter, MD MSc Patient Assessment and Outcome Committee Outcome of the American Association for the Surgery of Trauma Intestinal Obstruction ....................................................................................................... 49 Shannon McConnell Lamptey Garth H. Utter, MD MSc Patient Assessment and Outcome Committee Outcome of the American Association for the Surgery of Trauma Lysosomal Acid Lipase (LAL) Deficiency...................................................................... 51 Donna Pickett Uchenna Iloeje, MD Alexion Pharmaceticuls Mediastinitis ..................................................................................................................... 54 Shannon McConnell Lamptey Garth H. Utter, MD MSc Patient Assessment and Outcome Committee Outcome of the American Association for the Surgery of Trauma Megacolon ....................................................................................................................... 55 David Berglund, MD Non-Exudative AMD ....................................................................................................... 56 Shannon McConnell Lamptey Michael X Repka, M.D., MBA Medical Director of Government Affairs American Academy of Ophthalmology Professor of Ophthalmology and Pediatrics Johns Hopkins University School of Medicine Observation and evaluation of newborns for suspected conditions ruled out ................. 58 Cheryl Bullock Proposal to change Excludes Designations for Epilepsy ................................................. 61 Cheryl Bullock Pulmonary Hypertension ................................................................................................. 62 David Berglund, MD David Platt, MD Bayer HealthCare Pharmaceuticals Risk Level for Dental Carries .......................................................................................... 66 Traci Ramirez Subarachnoid hemorrhage ............................................................................................... 67 David Berglund, MD Vascular Disorders of Intestine ........................................................................................ 68 Shannon McConnell Lamptey Garth H. Utter, MD MSc Patient Assessment and Outcome Committee Outcome of the American Association for the Surgery of Trauma ICD-10-CM TABULAR OF DISEASES - PROPOSED ADDENDA ........................... 71 ICD-10-CM INDEX OF DISEASES - PROPOSED ADDENDA .................................. 76 3 ICD-10 Coordination and Maintenance Committee Meeting September 22-23, 2015 ICD-10 TIMELINE A timeline of important dates in the ICD-10 process is described below: September 22 –23, 2015 ICD-10 Coordination and Maintenance Committee meeting. Those who wish to attend the ICD-10 Coordination and Maintenance Committee meeting must have registered for the meeting online by September 11, 2015. You must bring an official form of picture identification (such as a driver’s license) in order to be admitted to the building. October 2015 Webcast of the September 22–23, 2015 ICD-10 Coordination and Maintenance Committee meeting will be posted on the CMS webpage as follows: https://www.cms.gov/Medicare/Coding/ICD9ProviderDiagnosticCodes/I CD-9-CM-C-and-M-Meeting-Materials.html Summary report of the Diagnosis part of the September 22–23, 2015 ICD-10 Coordination and Maintenance Committee meeting report will be posted on NCHS homepage as follows: http://www.cdc.gov/nchs/icd/icd9cm_maintenance.htm October 1, 2015 ICD-10-CM/PCS codes go into effect along with ICD-10 MS- DRGs October 1, 2015 New and revised ICD-10-CM and ICD-10-PCS codes go into effect along with DRG changes. Final addendum from previous years are available on web pages as follows: Diagnosis addendum: http://www.cdc.gov/nchs/icd/icd10cm.htm Due to the partial code freeze there are no updates to ICD-10-CM for October 1, 2015. Procedure addendum: https://www.cms.gov/Medicare/Coding/ICD10/2016-ICD-10-PCS-and- GEMs.html October 16, 2015 Deadline for receipt of public comments on proposed new codes if any discussed at the September 22-23, 2015 ICD-10 Coordination and Maintenance Committee meetings for implementation on April 1, 2016. November 2015 Any new ICD-10 codes required to capture new technology that will be implemented on the following April 1 will be announced. Information on any new codes to be implemented April 1, 2016 will be posted on the following websites: http://www.cdc.gov/nchs/icd/icd10cm.htm 4 ICD-10 Coordination and Maintenance Committee Meeting September 22-23, 2015 https://www.cms.gov/Medicare/Coding/ICD10/2016-ICD-10-PCS-and- GEMs.html November 13, 2015 Deadline for receipt of public comments on proposed new codes and revisions discussed at the September 22-23, 2015 ICD-10 Coordination and Maintenance Committee meetings for implementation on October 1, 2016. January 15, 2016 Deadline for requestors: Those members of the public requesting that topics be discussed at the March 9–10, 2016 ICD-10 Coordination

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    80 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us